Assessment of choriocapillaris/Sattler and Haller layer changes after intravitreal injection in eyes with neovascular age-related macular degeneration: aflibercept vs ranibizumab

被引:1
作者
Altunel, Orhan [1 ]
Ozsaygili, Cemal [2 ]
机构
[1] Kutahya Hlth Sci Univ, Sch Med, Dept Ophthalmol, Kutahya, Turkey
[2] Kayseri City Educ & Res Hosp, Dept Ophthalmol, Kayseri, Turkey
关键词
Aflibercept; Choriocapillaris; Sattler layer; Haller layer; Neovascular age-related macular degeneration; Ranibizumab; ENDOTHELIAL GROWTH-FACTOR; SUBFOVEAL CHOROIDAL THICKNESS; THERAPY; VEGF;
D O I
10.1007/s10384-021-00894-w
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate the changes in choriocapillaris (CC)/Sattler and Haller layer thicknesses in eyes with neovascular age-related macular degeneration (nAMD) after aflibercept or ranibizumab injections. Study design Retrospective. Methods A total of 70 eyes of 70 patients with treatment-naive exudative nAMD were treated with 3 consecutive injections of aflibercept (IVA) or ranibizumab (IVR). CC/Sattler and Haller layer thicknesses were measured at the nasal and temporal regions 1000 mu m from the center of the fovea by enhanced-depth imaging optical coherence tomography at baseline and after the 3 monthly intravitreal injections. In addition, the hyperfluorescence region (HF) was measured as the largest horizontal diameter of the hyperfluorescence area on the early-middle phase fluorescein angiographic images at baseline and after the 3 loading doses. Results After the 3 consecutive injections, the mean reductions in the nasal/temporal CC/Sattler layer thicknesses in the IVR and IVA groups were - 10.1 +/- 2.3/ - 8.5 +/- 1.8 and - 25.2 +/- 15.2/ - 19.4 +/- 12.8 mu m, respectively. Also, the mean reductions in the nasal/temporal Haller layer thicknesses in the IVR and IVA groups were - 6.5 +/- 3.6/ - 7.2 +/- 7.9 and - 9.5 +/- 8.0/ - 7.0 +/- 6.2 mu m, respectively. The changes in the CC/Sattler layer thicknesses of the IVA group were greater than those of the IVR group (P < .001); however, the changes in the Haller layer thickness were similar between the groups (P > .05). The mean decrease in the HF size of the IVA group was greater than that of the IVR group (P < .001). Conclusions Aflibercept treatment has a more pronounced effect on the CC/Sattler layer. Such results may indicate that aflibercept treatment influences choroidal neovascularization, possibly by reducing the capillary permeability associated with active neovascularization in the CC layer.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 31 条
  • [1] Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668
  • [2] Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Therapy on Choroidal Thickness in Neovascular Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography
    Branchini, Lauren
    Regatieri, Caio
    Adhi, Mehreen
    Flores-Moreno, Ignacio
    Manjunath, Varsha
    Fujimoto, James G.
    Duker, Jay S.
    [J]. JAMA OPHTHALMOLOGY, 2013, 131 (05) : 693 - 694
  • [3] Analysis of Choroidal Morphologic Features and Vasculature in Healthy Eyes Using Spectral-Domain Optical Coherence Tomography
    Branchini, Lauren A.
    Adhi, Mehreen
    Regatieri, Caio V.
    Nandakumar, Namrata
    Liu, Jonathan J.
    Laver, Nora
    Fujimoto, James G.
    Duker, Jay S.
    [J]. OPHTHALMOLOGY, 2013, 120 (09) : 1901 - 1908
  • [4] Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900
  • [5] Aqueous Humor Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Bevacizumab in Type 3 Versus Type 1 and 2 Neovascularization. A Prospective, Case-Control Study
    Dell'Omo, Roberto
    Cassetta, Marilluccia
    Dell'Omo, Ermanno
    di Salvatore, Angela
    Hughes, John M.
    Aceto, Fabiana
    Porcellini, Antonio
    Costagliola, Ciro
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (01) : 155 - 161
  • [6] Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration?
    Freund, K. Bailey
    Zweifel, Sandrine A.
    Engelbert, Michael
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (09): : 1333 - 1349
  • [7] Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Gharbiya, Magda
    Iannetti, Ludovico
    Parisi, Francesco
    De Vico, Umberto
    Mungo, Maria Laura
    Marenco, Marco
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [8] Efficacy of Intravitreal Injection of Aflibercept in Neovascular Age-Related Macular Degeneration With or Without Choroidal Vascular Hyperpermeability
    Hata, Masayuki
    Oishi, Akio
    Tsujikawa, Akitaka
    Yamashiro, Kenji
    Miyake, Masahiro
    Ooto, Sotaro
    Tamura, Hiroshi
    Nakanishi, Hideo
    Takahashi, Ayako
    Yoshikawa, Munemitsu
    Yoshimura, Nagahisa
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (12) : 7874 - 7880
  • [9] Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up
    Inan, Sibel
    Baysal, Zeki
    Inan, Umit Ubeyt
    [J]. CURRENT EYE RESEARCH, 2019, 44 (08) : 908 - 915
  • [10] Choroidal Thickness, Vascular Hyperpermeability, and Complement Factor H in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
    Jirarattanasopa, Pichai
    Ooto, Sotaro
    Nakata, Isao
    Tsujikawa, Akitaka
    Yamashiro, Kenji
    Oishi, Akio
    Yoshimura, Nagahisa
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (07) : 3663 - 3672